Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.08)
# 506
Out of 5,148 analysts
95
Total ratings
34.95%
Success rate
21.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVAX Novavax | Maintains: Buy | $11 → $16 | $10.11 | +58.26% | 3 | Feb 27, 2026 | |
| DWTX Dogwood Therapeutics | Reiterates: Buy | $12 | $2.87 | +317.97% | 4 | Feb 20, 2026 | |
| KZIA Kazia Therapeutics | Reiterates: Buy | $18 | $8.83 | +103.85% | 7 | Jan 28, 2026 | |
| PSTV Plus Therapeutics | Maintains: Buy | $2 → $1 | $0.30 | +233.78% | 14 | Jan 23, 2026 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | $11 → $27 | $17.89 | +50.92% | 4 | Jan 20, 2026 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $24 | $13.47 | +78.17% | 14 | Jan 12, 2026 | |
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.75 | +0.13% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $8.33 | +122.09% | 3 | Nov 6, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.24 | +579.12% | 2 | Sep 9, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $0.75 | +566.22% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $5.82 | +140.55% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $53.47 | -25.19% | 10 | Apr 1, 2025 |
Novavax
Feb 27, 2026
Maintains: Buy
Price Target: $11 → $16
Current: $10.11
Upside: +58.26%
Dogwood Therapeutics
Feb 20, 2026
Reiterates: Buy
Price Target: $12
Current: $2.87
Upside: +317.97%
Kazia Therapeutics
Jan 28, 2026
Reiterates: Buy
Price Target: $18
Current: $8.83
Upside: +103.85%
Plus Therapeutics
Jan 23, 2026
Maintains: Buy
Price Target: $2 → $1
Current: $0.30
Upside: +233.78%
Corvus Pharmaceuticals
Jan 20, 2026
Maintains: Buy
Price Target: $11 → $27
Current: $17.89
Upside: +50.92%
Alphatec Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $24
Current: $13.47
Upside: +78.17%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.75
Upside: +0.13%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $8.33
Upside: +122.09%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.24
Upside: +579.12%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.75
Upside: +566.22%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $5.82
Upside: +140.55%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $53.47
Upside: -25.19%